Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-26 @ 3:00 AM
Study NCT ID:
NCT01211002
Status:
UNKNOWN
Last Update Posted:
2010-09-29
First Post:
2010-09-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)
Sponsor:
Simcere Pharmaceutical Co., Ltd
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
sim201002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Zhenzhou Yang M.D.
Old Organization:
Daping Hospital and Research Institute of Surgery of Third Military Medical University
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |